Posts in tag
CSL Seqirus
Sponsor announces Tavneos discontinuation
Prescribers are being urged not to initiate treatment with Tavneos (avacopan) in new patients, with the drug to be withdrawn from the Australian market next year CSL Seqirus is set …
All content on AJP.com.au is restricted to registered users only.
To continue enjoying access to all the news, views, information and education you’ve come to trust, please login & stay in.
And if you don’t already have a login – register now!